Selected research
Industry Research
Female Oral Contraceptives Industry Research Report 2026
Market perspective
The global Female Oral Contraceptives market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Female Oral Contraceptives is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Female Oral Contraceptives is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Female Oral Contraceptives is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Female Oral Contraceptives include Allergan,plc (Actavis), Mankind Pharma, Piramal Enterprises, Syzygy Healthcare, Bayer, Ferring B.V, Pfizer, Merck and Teva Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Female Oral Contraceptives market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Female Oral Contraceptives Market by Company
Allergan,plc (Actavis)
Mankind Pharma
Piramal Enterprises
Syzygy Healthcare
Bayer
Ferring B.V
Pfizer
Merck
Teva Pharmaceutical
Janssen Global Services
Female Oral Contraceptives Segment by Type
Continuous Use Pill
Combination Pill
Progestin-only Pill
Female Oral Contraceptives Segment by Application
Online Sales
Offline Sales
Female Oral Contraceptives Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Female Oral Contraceptives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Female Oral Contraceptives and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Female Oral Contraceptives.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Female Oral Contraceptives manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Female Oral Contraceptives by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Female Oral Contraceptives in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Continuous Use Pill
- Combination Pill
- Progestin-only Pill
Applications
- Online Sales
- Offline Sales
Companies covered
- Allergan,plc (Actavis)
- Mankind Pharma
- Piramal Enterprises
- Syzygy Healthcare
- Bayer
- Ferring B.V
- Pfizer
- Merck
- Teva Pharmaceutical
- Janssen Global Services
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Female Oral Contraceptives Market Size (2021-2032)
- 2.2.2 Global Female Oral Contraceptives Sales (2021-2032)
- 2.2.3 Global Female Oral Contraceptives Market Average Price (2021-2032)
- 2.3 Female Oral Contraceptives by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Continuous Use Pill
- 2.3.3 Combination Pill
- 2.3.4 Progestin-only Pill
- 2.4 Female Oral Contraceptives by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Online Sales
- 2.4.3 Offline Sales
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Female Oral Contraceptives Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Female Oral Contraceptives Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Female Oral Contraceptives Revenue of Manufacturers (2021-2026)
- 3.4 Global Female Oral Contraceptives Average Price by Manufacturers (2021-2026)
- 3.5 Global Female Oral Contraceptives Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Female Oral Contraceptives, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Female Oral Contraceptives, Product Type & Application
- 3.8 Global Manufacturers of Female Oral Contraceptives, Established Date
- 3.9 Global Female Oral Contraceptives Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Allergan,plc (Actavis)
- 4.1.1 Allergan,plc (Actavis) Company Information
- 4.1.2 Allergan,plc (Actavis) Business Overview
- 4.1.3 Allergan,plc (Actavis) Female Oral Contraceptives Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Allergan,plc (Actavis) Female Oral Contraceptives Product Portfolio
- 4.1.5 Allergan,plc (Actavis) Recent Developments
- 4.2 Mankind Pharma
- 4.2.1 Mankind Pharma Company Information
- 4.2.2 Mankind Pharma Business Overview
- 4.2.3 Mankind Pharma Female Oral Contraceptives Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Mankind Pharma Female Oral Contraceptives Product Portfolio
- 4.2.5 Mankind Pharma Recent Developments
- 4.3 Piramal Enterprises
- 4.3.1 Piramal Enterprises Company Information
- 4.3.2 Piramal Enterprises Business Overview
- 4.3.3 Piramal Enterprises Female Oral Contraceptives Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Piramal Enterprises Female Oral Contraceptives Product Portfolio
- 4.3.5 Piramal Enterprises Recent Developments
- 4.4 Syzygy Healthcare
- 4.4.1 Syzygy Healthcare Company Information
- 4.4.2 Syzygy Healthcare Business Overview
- 4.4.3 Syzygy Healthcare Female Oral Contraceptives Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Syzygy Healthcare Female Oral Contraceptives Product Portfolio
- 4.4.5 Syzygy Healthcare Recent Developments
- 4.5 Bayer
- 4.5.1 Bayer Company Information
- 4.5.2 Bayer Business Overview
- 4.5.3 Bayer Female Oral Contraceptives Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Bayer Female Oral Contraceptives Product Portfolio
- 4.5.5 Bayer Recent Developments
- 4.6 Ferring B.V
- 4.6.1 Ferring B.V Company Information
- 4.6.2 Ferring B.V Business Overview
- 4.6.3 Ferring B.V Female Oral Contraceptives Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Ferring B.V Female Oral Contraceptives Product Portfolio
- 4.6.5 Ferring B.V Recent Developments
- 4.7 Pfizer
- 4.7.1 Pfizer Company Information
- 4.7.2 Pfizer Business Overview
- 4.7.3 Pfizer Female Oral Contraceptives Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Pfizer Female Oral Contraceptives Product Portfolio
- 4.7.5 Pfizer Recent Developments
- 4.8 Merck
- 4.8.1 Merck Company Information
- 4.8.2 Merck Business Overview
- 4.8.3 Merck Female Oral Contraceptives Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Merck Female Oral Contraceptives Product Portfolio
- 4.8.5 Merck Recent Developments
- 4.9 Teva Pharmaceutical
- 4.9.1 Teva Pharmaceutical Company Information
- 4.9.2 Teva Pharmaceutical Business Overview
- 4.9.3 Teva Pharmaceutical Female Oral Contraceptives Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Teva Pharmaceutical Female Oral Contraceptives Product Portfolio
- 4.9.5 Teva Pharmaceutical Recent Developments
- 4.10 Janssen Global Services
- 4.10.1 Janssen Global Services Company Information
- 4.10.2 Janssen Global Services Business Overview
- 4.10.3 Janssen Global Services Female Oral Contraceptives Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Janssen Global Services Female Oral Contraceptives Product Portfolio
- 4.10.5 Janssen Global Services Recent Developments
5 Global Female Oral Contraceptives Market Scenario by Region
- 5.1 Global Female Oral Contraceptives Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Female Oral Contraceptives Sales by Region: 2021-2032
- 5.2.1 Global Female Oral Contraceptives Sales by Region: 2021-2026
- 5.2.2 Global Female Oral Contraceptives Sales by Region: 2027-2032
- 5.3 Global Female Oral Contraceptives Revenue by Region: 2021-2032
- 5.3.1 Global Female Oral Contraceptives Revenue by Region: 2021-2026
- 5.3.2 Global Female Oral Contraceptives Revenue by Region: 2027-2032
- 5.4 North America Female Oral Contraceptives Market Facts & Figures by Country
- 5.4.1 North America Female Oral Contraceptives Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Female Oral Contraceptives Sales by Country (2021-2032)
- 5.4.3 North America Female Oral Contraceptives Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Female Oral Contraceptives Market Facts & Figures by Country
- 5.5.1 Europe Female Oral Contraceptives Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Female Oral Contraceptives Sales by Country (2021-2032)
- 5.5.3 Europe Female Oral Contraceptives Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Female Oral Contraceptives Market Facts & Figures by Country
- 5.6.1 Asia Pacific Female Oral Contraceptives Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Female Oral Contraceptives Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Female Oral Contraceptives Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Female Oral Contraceptives Market Facts & Figures by Country
- 5.7.1 South America Female Oral Contraceptives Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Female Oral Contraceptives Sales by Country (2021-2032)
- 5.7.3 South America Female Oral Contraceptives Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Female Oral Contraceptives Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Female Oral Contraceptives Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Female Oral Contraceptives Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Female Oral Contraceptives Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Female Oral Contraceptives Sales by Type (2021-2032)
- 6.1.1 Global Female Oral Contraceptives Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Female Oral Contraceptives Sales Market Share by Type (2021-2032)
- 6.2 Global Female Oral Contraceptives Revenue by Type (2021-2032)
- 6.2.1 Global Female Oral Contraceptives Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Female Oral Contraceptives Revenue Market Share by Type (2021-2032)
- 6.3 Global Female Oral Contraceptives Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Female Oral Contraceptives Sales by Application (2021-2032)
- 7.1.1 Global Female Oral Contraceptives Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Female Oral Contraceptives Sales Market Share by Application (2021-2032)
- 7.2 Global Female Oral Contraceptives Revenue by Application (2021-2032)
- 7.2.1 Global Female Oral Contraceptives Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Female Oral Contraceptives Revenue Market Share by Application (2021-2032)
- 7.3 Global Female Oral Contraceptives Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Female Oral Contraceptives Value Chain Analysis
- 8.1.1 Female Oral Contraceptives Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Female Oral Contraceptives Production Mode & Process
- 8.2 Female Oral Contraceptives Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Female Oral Contraceptives Distributors
- 8.2.3 Female Oral Contraceptives Customers
9 Global Female Oral Contraceptives Analyzing Market Dynamics
- 9.1 Female Oral Contraceptives Industry Trends
- 9.2 Female Oral Contraceptives Industry Drivers
- 9.3 Female Oral Contraceptives Industry Opportunities and Challenges
- 9.4 Female Oral Contraceptives Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst